Aterian receives Nasdaq bid price deficiency notice; CFO terminated, CEO interim CFO

Aterian, Inc.

Nasdaq notified Aterian of non-compliance with $1.00 min bid price rule; 180-day cure period until March 1, 2027.
CFO Joshua Feldman terminated Sep 4, 2026 per transition agreement; receives severance benefits.
CEO David E. Lazar named interim CFO while company searches for full-time replacement.
Company may face delisting if not compliant by March 1, 2027; could get second 180-day period.

Featured in Daily 8-K Digest

Selected #5 for 2026-09-08. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.